Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 76

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 76
---
 will automatically update and supersede that information. Any
statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded
for purposes of this prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated
by reference modifies or replaces that statement.

We incorporate by reference
our documents listed below and any future filings made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange
Act of 1934, as amended, which we refer to as the “Exchange Act” in this prospectus, between the date of this prospectus and
the termination of the offering of the securities described in this prospectus. This prospectus and any accompanying prospectus supplement
incorporate by reference the documents set forth below that have previously been filed with the SEC:

In addition, all reports
and other documents filed by us pursuant to the Exchange Act after the date of the initial registration statement and prior to effectiveness
of the registration statement shall be deemed to be incorporated by reference into this prospectus and deemed to be a part of this prospectus
from the date of filing of such reports and documents. Notwithstanding the foregoing, we are not incorporating by reference any documents
or portions thereof that are not deemed “filed” with the SEC, including our Compensation Committee report and performance
graph or any information furnished pursuant to Items 2.02 or 7.01 of Form 8-K or related exhibits furnished pursuant to Item 9.01 of Form
8-K.

You may request a free copy
of any of the documents incorporated by reference in this prospectus (other than exhibits, unless they are specifically incorporated by
reference in the documents) by writing or telephoning us at the following address:

<div align='center'>Incannex Healthcare Inc.

Suite 105, 8 Century Circuit

NSW 2153

Norwest, Australia

Attn: Investor Relations

+61 409 840 786</div>

Exhibits to the filings will
not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus
supplement.

<div align='center'>27

Up to $ 16,768,099 of Shares of

Common Stock

PROSPECTUS SUPPLEMENT

A.G.P.

April 7, 2025</div>